Bisphosphonates - Clinical applications in osteoporosis

Australian Prescriber

Volumn 23, Issue 6, 2000, Pages 133-136

  Ebeling, Peter R ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b Australian and New Zealand Bone and Mineral Society   (New Zealand)

Author keywords

Alendronate; Bone mineral density; Etidronate; Fractures; Risedronate

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENCY; FEMALE; HUMAN; POSTMENOPAUSE OSTEOPOROSIS; SPINE FRACTURE;

EID: 0034529422     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2000.145     Document Type: Article

References (14)

1. Bone density at various sites for prediction of hip fractures
2. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy
3. Use of cyclical etidronate and prevention of non-vertebral fractures
4. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
5. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
6. Bone density measurement
7. Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial
8. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
9. Alendronate for the treatment of osteoporosis in men
10. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis
11. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
12. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomised trial
13. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy
14. Risedronate prevents bone loss in early postmenopausal women